In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
February 2nd, 2010 | 28 | Yes |
Popular Name: AT9283 AT9283
Find On: PubMed — Wikipedia — Google
CAS Numbers: 896466-04-9 , [896466-04-9]
1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea
4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 1.23 | 2.15 | -10.32 | 4 | 9 | 0 | 111 | 381.44 | 5 | ↓ |
Lo Low (pH 4.5-6) | 1.23 | 4.38 | -50.13 | 5 | 9 | 1 | 112 | 382.448 | 5 | ↓ |
Lo Low (pH 4.5-6) | 1.23 | 4.72 | -95.17 | 6 | 9 | 2 | 113 | 383.456 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.11e-02 g/l | DrugBank-experimental |
Target | Bcr-Abl, JAK, Aurora Kinase | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ABL1-1-E | Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4 | 0.42 | Binding ≤ 10μM |
AURKA-2-E | Serine/threonine-protein Kinase Aurora-A (cluster #2 Of 3), Eukaryotic | Eukaryotes | 3 | 0.43 | Binding ≤ 10μM |
AURKB-1-E | Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3 | 0.43 | Binding ≤ 10μM |
FGFR1-1-E | Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
FGFR2-1-E | Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
FGFR3-1-E | Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
JAK2-1-E | Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
JAK3-2-E | Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
KPCD1-1-E | Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
KS6A2-1-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
KS6A3-1-E | Ribosomal Protein S6 Kinase Alpha 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
KS6A4-1-E | Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
MERTK-1-E | Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
PDK1-1-E | Pyruvate Dehydrogenase Kinase Isoform 1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
RET-1-E | Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
ST17A-1-E | Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
TYK2-1-E | Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
VGFR1-1-E | Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 10 | 0.40 | Binding ≤ 10μM |
VGFR3-1-E | Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
YES-1-E | Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1 | 0.45 | Binding ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 12 | 0.40 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 10 | 0.40 | Binding ≤ 1μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 1 | 0.45 | Binding ≤ 1μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 10 | 0.40 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1 | 0.45 | Binding ≤ 1μM |
KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 10 | 0.40 | Binding ≤ 1μM |
MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 1 | 0.45 | Binding ≤ 1μM |
PDK1_HUMAN | Q15118 | Pyruvate Dehydrogenase Kinase Isoform 1, Human | 10 | 0.40 | Binding ≤ 1μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 1 | 0.45 | Binding ≤ 1μM |
KS6A3_HUMAN | P51812 | Ribosomal Protein S6 Kinase Alpha 3, Human | 1 | 0.45 | Binding ≤ 1μM |
KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 10 | 0.40 | Binding ≤ 1μM |
ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 10 | 0.40 | Binding ≤ 1μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 3 | 0.43 | Binding ≤ 1μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 3 | 0.43 | Binding ≤ 1μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 4 | 0.42 | Binding ≤ 1μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1 | 0.45 | Binding ≤ 1μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 1 | 0.45 | Binding ≤ 1μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 10 | 0.40 | Binding ≤ 1μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 1 | 0.45 | Binding ≤ 1μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 1 | 0.45 | Binding ≤ 1μM |
YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 1 | 0.45 | Binding ≤ 1μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 10 | 0.40 | Binding ≤ 1μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 10 | 0.40 | Binding ≤ 1μM |
VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 1 | 0.45 | Binding ≤ 1μM |
FGFR1_HUMAN | P11362 | Fibroblast Growth Factor Receptor 1, Human | 10 | 0.40 | Binding ≤ 10μM |
FGFR2_HUMAN | P21802 | Fibroblast Growth Factor Receptor 2, Human | 1 | 0.45 | Binding ≤ 10μM |
FGFR3_HUMAN | P22607 | Fibroblast Growth Factor Receptor 3, Human | 10 | 0.40 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 1 | 0.45 | Binding ≤ 10μM |
KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 10 | 0.40 | Binding ≤ 10μM |
MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 1 | 0.45 | Binding ≤ 10μM |
PDK1_HUMAN | Q15118 | Pyruvate Dehydrogenase Kinase Isoform 1, Human | 10 | 0.40 | Binding ≤ 10μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 1 | 0.45 | Binding ≤ 10μM |
KS6A3_HUMAN | P51812 | Ribosomal Protein S6 Kinase Alpha 3, Human | 1 | 0.45 | Binding ≤ 10μM |
KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 10 | 0.40 | Binding ≤ 10μM |
ST17A_HUMAN | Q9UEE5 | Serine/threonine-protein Kinase 17A, Human | 10 | 0.40 | Binding ≤ 10μM |
AURKA_HUMAN | O14965 | Serine/threonine-protein Kinase Aurora-A, Human | 3 | 0.43 | Binding ≤ 10μM |
AURKB_HUMAN | Q96GD4 | Serine/threonine-protein Kinase Aurora-B, Human | 3 | 0.43 | Binding ≤ 10μM |
ABL1_HUMAN | P00519 | Tyrosine-protein Kinase ABL, Human | 4 | 0.42 | Binding ≤ 10μM |
JAK2_HUMAN | O60674 | Tyrosine-protein Kinase JAK2, Human | 1 | 0.45 | Binding ≤ 10μM |
JAK3_HUMAN | P52333 | Tyrosine-protein Kinase JAK3, Human | 1 | 0.45 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 10 | 0.40 | Binding ≤ 10μM |
RET_HUMAN | P07949 | Tyrosine-protein Kinase Receptor RET, Human | 1 | 0.45 | Binding ≤ 10μM |
TYK2_HUMAN | P29597 | Tyrosine-protein Kinase TYK2, Human | 1 | 0.45 | Binding ≤ 10μM |
YES_HUMAN | P07947 | Tyrosine-protein Kinase YES, Human | 1 | 0.45 | Binding ≤ 10μM |
VGFR1_HUMAN | P17948 | Vascular Endothelial Growth Factor Receptor 1, Human | 10 | 0.40 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 10 | 0.40 | Binding ≤ 10μM |
VGFR3_HUMAN | P35916 | Vascular Endothelial Growth Factor Receptor 3, Human | 1 | 0.45 | Binding ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 12 | 0.40 | Functional ≤ 10μM |
Description | Species |
---|---|
Activated point mutants of FGFR2 | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
CD28 co-stimulation | |
CDO in myogenesis | |
Cell surface interactions at the vascular wall | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
Degradation of beta-catenin by the destruction complex | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
ERK/MAPK targets | |
Factors involved in megakaryocyte development and platelet production | |
FCGR activation | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Growth hormone receptor signaling | |
Integrin cell surface interactions | |
Interferon alpha/beta signaling | |
Interferon gamma signaling | |
Interleukin receptor SHC signaling | |
Interleukin-2 signaling | |
Interleukin-3, 5 and GM-CSF signaling | |
Interleukin-6 signaling | |
Interleukin-7 signaling | |
misspliced GSK3beta mutants stabilize beta-catenin | |
Mitotic Prometaphase | |
Neurophilin interactions with VEGF and VEGFR | |
PECAM1 interactions | |
Prolactin receptor signaling | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of HSF1-mediated heat shock response | |
Regulation of IFNA signaling | |
Regulation of IFNG signaling | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of pyruvate dehydrogenase (PDH) complex | |
Regulation of signaling by CBL | |
Resolution of Sister Chromatid Cohesion | |
RMTs methylate histone arginines | |
Role of Abl in Robo-Slit signaling | |
RSK activation | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
Senescence-Associated Secretory Phenotype (SASP) | |
Separation of Sister Chromatids | |
Signaling by activated point mutants of FGFR1 | |
Signaling by activated point mutants of FGFR3 | |
Signaling by ERBB2 | |
Signaling by FGFR mutants | |
Signaling by FGFR2 amplification mutants | |
Signaling by FGFR3 mutants | |
Signaling by Leptin | |
Signaling by SCF-KIT | |
Sphingolipid de novo biosynthesis | |
t(4;14) translocations of FGFR3 | |
T41 mutants of beta-catenin aren't phosphorylated | |
truncations of AMER1 destabilize the destruction complex | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.